Literature DB >> 29670689

Novel Triterpenone for Treatment of Viral Diseases-HIV Inhibitors.

Robert B Kargbo1.   

Abstract

Entities:  

Year:  2018        PMID： 29670689      PMCID： PMC5900338          DOI： 10.1021/acsmedchemlett.8b00113

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  5 in total

Review 1.  Chimeric antigen receptor engineered stem cells: a novel HIV therapy.

Authors:  Anjie Zhen; Mayra A Carrillo; Scott G Kitchen
Journal:  Immunotherapy       Date:  2017-03       Impact factor: 4.196

Review 2.  Early infant diagnosis of HIV: review of current and innovative practices.

Authors:  Francesca Celletti; Gayle Sherman; Ahmad H Mazanderani
Journal:  Curr Opin HIV AIDS       Date:  2017-03       Impact factor: 4.283

Review 3.  Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring.

Authors:  Jose R Castillo-Mancilla; Jessica E Haberer
Journal:  Curr HIV/AIDS Rep       Date:  2018-02       Impact factor: 5.071

Review 4.  Where are we with injectables against HIV infection and what are the remaining challenges?

Authors:  Said A Hassounah; Thibault Mesplède
Journal:  Expert Rev Anti Infect Ther       Date:  2018-01-25       Impact factor: 5.091

5.  Active ingredients of a person-centred intervention for people on HIV treatment: analysis of mixed methods trial data.

Authors:  Keira Lowther; Richard Harding; Victoria Simms; Aabid Ahmed; Zipporah Ali; Nancy Gikaara; Lorraine Sherr; Hellen Kariuki; Irene J Higginson; Lucy Ellen Selman
Journal:  BMC Infect Dis       Date:  2018-01-10       Impact factor: 3.090
  5 in total
  1 in total

Review 1.  Recent advances in natural anti-HIV triterpenoids and analogs.

Authors:  Hai-Feng Wu; Susan L Morris-Natschke; Xu-Dong Xu; Mei-Hua Yang; Yung-Yi Cheng; Shi-Shan Yu; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2020-07-14       Impact factor: 12.944
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.